JP2005532289A5 - - Google Patents

Download PDF

Info

Publication number
JP2005532289A5
JP2005532289A5 JP2003583385A JP2003583385A JP2005532289A5 JP 2005532289 A5 JP2005532289 A5 JP 2005532289A5 JP 2003583385 A JP2003583385 A JP 2003583385A JP 2003583385 A JP2003583385 A JP 2003583385A JP 2005532289 A5 JP2005532289 A5 JP 2005532289A5
Authority
JP
Japan
Prior art keywords
polymer
sustained release
hydrophobic polymer
hydrophobic
hydrophilic polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003583385A
Other languages
English (en)
Other versions
JP2005532289A (ja
Filing date
Publication date
Priority claimed from US10/120,501 external-priority patent/US7125563B2/en
Application filed filed Critical
Publication of JP2005532289A publication Critical patent/JP2005532289A/ja
Publication of JP2005532289A5 publication Critical patent/JP2005532289A5/ja
Pending legal-status Critical Current

Links

Description

上記徐放剤は疎水性ポリマーを含むことができる。上記疎水性ポリマーはエチルセルロースを含むことができる。
上記徐放性コーティングは疎水性ポリマー及び親水性ポリマーを含むことができる。上記疎水性ポリマーはエチルセルロースを含むことができ、上記親水性ポリマーはメチルセルロースを含むことができる。
上記徐放性コーティングはエチルセルロース及びメチルセルロースを含むことができ、上記徐放剤はエチルセルロースを含むことができる。
上記徐放性コーティングの疎水性ポリマー及び親水性ポリマーは、疎水性ポリマー対親水性ポリマーの重量比55-65:45-35、好ましくは疎水性ポリマー対親水性ポリマーの重量比57:43で存在することができる。

Claims (1)

  1. 当該徐放性コーティングの疎水性ポリマー及び親水性ポリマーが、当該疎水性ポリマー対当該親水性ポリマーの重量比57:43で存在する、請求項７に記載の徐放性錠剤。
JP2003583385A 2002-04-12 2003-04-11 持続放出性医薬製剤及びその製造方法 Pending JP2005532289A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/120,501 US7125563B2 (en) 2002-04-12 2002-04-12 Sustained release pharmaceutical preparations and methods for producing the same
PCT/US2003/009210 WO2003086364A1 (en) 2002-04-12 2003-04-11 Sustained release pharmaceutical prepartations and methods for producing the same

Publications (2)

Publication Number Publication Date
JP2005532289A JP2005532289A (ja) 2005-10-27
JP2005532289A5 true JP2005532289A5 (ja) 2006-06-01

Family

ID=29214431

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003583385A Pending JP2005532289A (ja) 2002-04-12 2003-04-11 持続放出性医薬製剤及びその製造方法

Country Status (10)

Country Link
US (3) US7125563B2 (ja)
EP (1) EP1494653A1 (ja)
JP (1) JP2005532289A (ja)
CN (1) CN1655765A (ja)
AU (1) AU2003218397A1 (ja)
CA (1) CA2481667A1 (ja)
HR (1) HRP20040945A2 (ja)
PL (1) PL373328A1 (ja)
RU (1) RU2004133532A (ja)
WO (1) WO2003086364A1 (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203296D0 (en) 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
ES2272914T3 (es) * 2003-05-20 2007-05-01 Ethypharm Composicion farmaceutica oral de liberacion sostenida.
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
CA2645855C (en) 2006-03-16 2015-02-03 Tris Pharma, Inc. Modified release formulations containing drug-ion exchange resin complexes
CN101453993A (zh) * 2006-04-03 2009-06-10 伊萨·奥迪迪 含有机溶胶涂层的受控释放递送物件
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
WO2009147665A1 (en) * 2008-06-02 2009-12-10 Dexcel Ltd Process for manufacture of a medicament with granulation and pan coating
WO2011102506A1 (ja) * 2010-02-22 2011-08-25 第一三共株式会社 経口用徐放性固形製剤
EP2540318B1 (en) 2010-02-22 2018-10-24 Daiichi Sankyo Company, Limited Sustained-release solid preparation for oral use
US8623409B1 (en) 2010-10-20 2014-01-07 Tris Pharma Inc. Clonidine formulation
KR102127625B1 (ko) 2012-09-03 2020-06-29 다이이찌 산쿄 가부시키가이샤 하이드로모르폰염산염 함유의 경구용 서방성 의약 조성물
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
US9949964B2 (en) * 2016-09-07 2018-04-24 Saniona A/S Tesofensine compositions
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
US11918689B1 (en) 2020-07-28 2024-03-05 Tris Pharma Inc Liquid clonidine extended release composition

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264573A (en) 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
US4252786A (en) * 1979-11-16 1981-02-24 E. R. Squibb & Sons, Inc. Controlled release tablet
US4327725A (en) 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4783337A (en) 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4765989A (en) 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US4612008A (en) 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4587117A (en) 1983-06-06 1986-05-06 Alza Corporation Medical device for delivering drug to pH environments greater than 3.5
US4503030A (en) 1983-06-06 1985-03-05 Alza Corporation Device for delivering drug to certain pH environments
US4751071A (en) 1983-12-01 1988-06-14 Alza Corporation Composition comprising salbutamol
US4851229A (en) 1983-12-01 1989-07-25 Alza Corporation Composition comprising a therapeutic agent and a modulating agent
US4777049A (en) 1983-12-01 1988-10-11 Alza Corporation Constant release system with pulsed release
US4695591A (en) * 1985-03-29 1987-09-22 Schering Corporation Controlled release dosage forms comprising hydroxypropylmethylcellulose
IT1213080B (it) * 1986-06-17 1989-12-07 Recordati Chem Pharm Sistemi terapeutico per la cessione controllata di farmaci.
US5254347A (en) 1988-03-31 1993-10-19 Tanabe Seiyaku Co., Ltd. Controlled release pharmaceutical preparation and method for producing the same
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
IL92966A (en) 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5248516A (en) * 1989-12-19 1993-09-28 Fmc Corporation Film-forming composition: method of producing same and use for coating pharmaceuticals and foods and the like
IE82916B1 (en) 1990-11-02 2003-06-11 Elan Corp Plc Formulations and their use in the treatment of neurological diseases
US5075115A (en) * 1990-04-02 1991-12-24 Fmc Corporation Process for polymerizing poly(lactic acid)
IE61651B1 (en) 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
ATE192335T1 (de) 1990-12-20 2000-05-15 Warner Jenkinson Co Inc Filmbildende zusammensetzungen aus feuchtem pulver
JPH04235914A (ja) * 1991-01-18 1992-08-25 Kyowa Hakko Kogyo Co Ltd 徐放性製剤
FI93924C (fi) * 1991-09-17 1995-06-26 Martti Lauri Antero Marvola Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
DE69207863T2 (de) * 1991-11-13 1996-06-05 Glaxo Canada Vorrichtung zur kontrollierten Wirkstoffreigabe
US5681585A (en) 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5543154A (en) 1991-12-27 1996-08-06 Merck & Co., Inc. Controlled release nifedipine delivery device
JP2665858B2 (ja) * 1992-05-30 1997-10-22 日本ヘキスト・マリオン・ルセル株式会社 持効性塩酸オキシブチニン製剤
IL119660A (en) 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
KR100337985B1 (ko) 1993-06-14 2002-11-23 얀센 파마슈티카 엔.브이. 아스테미졸및슈도에페드린의서방성필름-코팅정제
US5472714A (en) 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
US5662933A (en) * 1993-09-09 1997-09-02 Edward Mendell Co., Inc. Controlled release formulation (albuterol)
US6210714B1 (en) 1993-11-23 2001-04-03 Euro-Celtique S.A. Immediate release tablet cores of acetaminophen having sustained-release coating
US5500227A (en) 1993-11-23 1996-03-19 Euro-Celtique, S.A. Immediate release tablet cores of insoluble drugs having sustained-release coating
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
US5464633A (en) 1994-05-24 1995-11-07 Jagotec Ag Pharmaceutical tablets releasing the active substance after a definite period of time
SE9402431D0 (sv) 1994-07-08 1994-07-08 Astra Ab New tablet formulation
WO1996019974A1 (fr) 1994-12-27 1996-07-04 Kanebo, Ltd. Preparation a liberation prolongee
IL139728A (en) 1995-01-09 2003-06-24 Penwest Pharmaceuticals Compan Aqueous slurry composition containing microcrystalline cellulose for preparing a pharmaceutical excipient
US6262115B1 (en) 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US5912268A (en) 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
US5674895A (en) 1995-05-22 1997-10-07 Alza Corporation Dosage form comprising oxybutynin
US6124355A (en) 1995-05-22 2000-09-26 Guittard; George V. Oxybutynin therapy
US5945124A (en) 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
SE9600072D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients II
US6245351B1 (en) 1996-03-07 2001-06-12 Takeda Chemical Industries, Ltd. Controlled-release composition
FR2752162B1 (fr) * 1996-08-07 1998-11-06 Jouveinal Lab Comprime de maleate de trimebutine pellicule
US5780055A (en) 1996-09-06 1998-07-14 University Of Maryland, Baltimore Cushioning beads and tablet comprising the same capable of forming a suspension
US5807580A (en) 1996-10-30 1998-09-15 Mcneil-Ppc, Inc. Film coated tablet compositions having enhanced disintegration characteristics
US5837379A (en) 1997-01-31 1998-11-17 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US5751524A (en) * 1997-03-10 1998-05-12 Square D Company Ground fault protection circuit for a multiple source system
US6210710B1 (en) 1997-04-28 2001-04-03 Hercules Incorporated Sustained release polymer blend for pharmaceutical applications
ID24259A (id) * 1997-09-25 2000-07-13 Bayer Ag Formulasi obat yang memiliki pelepasan senyawa aktif terkontrol
TW477702B (en) 1997-10-23 2002-03-01 Dev Center Biotechnology Controlled release tacrine dosage form
US6156347A (en) 1998-01-21 2000-12-05 Bio-Dar Ltd. Controlled release chromium picolinate
US6251430B1 (en) 1998-02-04 2001-06-26 Guohua Zhang Water insoluble polymer based sustained release formulation

Similar Documents

Publication Publication Date Title
JP2005532289A5 (ja)
JP2007532572A5 (ja)
JP2005529870A5 (ja)
WO2006015944A3 (en) Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
WO2003000237A8 (en) Biodegradable polymer coompositions
WO2010037854A3 (fr) Forme pharmaceutique orale a base de microgranules a liberation prolongee resistante a l' alcool
CA2306333A1 (en) Oral morphine multiparticulate formulation
CA2433032A1 (en) Sustained release drug delivery devices with coated drug cores
JP2003503454A5 (ja)
JP2009517468A5 (ja)
WO2004056337A3 (en) Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
WO2005048979A3 (en) Pharmaceutical composition having casing with multiple micro tablets
JP2008509724A5 (ja)
WO2005079748A3 (en) Pharmaceutical preparation for sustained release of a pharmaceutically active ingredient
WO1998029095A3 (en) Sustained release cisapride mini-tablet formulation
JP2004532847A5 (ja)
JP2003530442A5 (ja)
JP2003517386A5 (ja)
JP2006512466A5 (ja)
WO2005079750A3 (en) Films for use as dosage forms
CA2509073A1 (en) A catalytic composition and its preparation and use for preparing polymers from ethylenically unsaturated monomers
JP2004283135A5 (ja)
JP2003510400A5 (ja)
CA2417887A1 (en) Particulate composition of eletriptan
JP2005526061A5 (ja)